SOMA HEALTH vs Neurogan: Urolithin A Compared

SOMA HEALTH and Neurogan both sell urolithin A, but they take different routes to the same molecule: a raspberry gummy versus capsules. This guide explains what urolithin A actually does, what the human evidence supports, where each format helps, and how to choose without the marketing noise.

Same molecule, different delivery

Urolithin A is a single, well-defined compound, so the first thing to understand is that no brand has a proprietary version of the molecule itself. What differs between companies is the dose per serving, the format (gummy, capsule, powder), the testing and transparency, and the overall value. SOMA HEALTH delivers 1,000 mg of urolithin A across a four-gummy daily serving in a sugar-free raspberry gummy. Neurogan offers urolithin A primarily in capsule form across several potencies. Because Neurogan periodically updates its lineup and per-capsule amounts, check the current label for their exact dose rather than relying on any number quoted elsewhere.

This is a comparison written by a competitor: SOMA HEALTH makes a urolithin A product, so read this as an honest framework rather than a neutral third party. The science below applies to the ingredient no matter whose bottle it comes in, and we have kept it strictly to what human and preclinical studies actually show.

What urolithin A is, in plain terms

Urolithin A is not something you eat directly. It is a gut postbiotic: your microbiome converts ellagitannins and ellagic acid, found in pomegranate, walnuts, and certain berries, into urolithin A. The catch is that conversion varies enormously from person to person. Studies suggest a meaningful share of people carry a gut community that produces little to no urolithin A even when they eat plenty of the precursor foods. That variability is the core reason a standardized supplement exists at all: it delivers a known amount of the finished compound rather than hoping your microbiome makes it.

Mechanistically, urolithin A is studied for its role in mitophagy — the cellular housekeeping process that identifies worn-out mitochondria and recycles them so fresher, better-functioning ones can take their place. Because mitochondria are the energy plants of nearly every cell, researchers are interested in whether supporting this clean-up process helps tissues that depend heavily on energy, such as muscle. To go deeper on the biology, see our urolithin A guide and our explainer on what mitophagy is.

The human evidence, organized by strength

Established human findings

The most relevant human work is in muscle and mitochondrial function. The first-in-human trial by Andreux and colleagues (2019, Nature Metabolism) reported that urolithin A was safe and well tolerated at doses up to 1,000 mg per day and produced a mitochondrial gene-expression signature in older adults. Liu, D'Amico and colleagues (2022, JAMA Network Open) followed older adults for roughly four months and observed improvements in muscle endurance, measured as the number of muscle contractions before fatigue. Singh and colleagues (2022, Cell Reports Medicine) tested 500 mg and 1,000 mg daily in middle-aged adults over four months and reported benefits for muscle strength and aspects of exercise performance.

Newer and emerging human research

More recent trials extend the picture. A 2024 randomized controlled trial in the Journal of the International Society of Sports Nutrition ran eight weeks in resistance-trained men and looked at endurance and recovery markers. A 2025 trial in Nature Aging (about 28 days) reported support for immune-cell mitochondrial health in midlife adults, part of the emerging interest in so-called inflammaging. A separate 2025 trial in distance runners added performance data. Taken together, these are encouraging, but a 2024 systematic review in Ageing Research Reviews is blunt about the limits: the human evidence is still emerging, trials are relatively short, and sample sizes are modest.

Preclinical research (animal and cell only — not human proof)

Much of the excitement traces back to Ryu and colleagues (2016, Nature Medicine), the foundational study showing urolithin A triggered mitophagy, extended lifespan in the worm C. elegans, and improved muscle function in rodents. D'Amico and colleagues (2022, Aging Cell) explored joint and cartilage mitochondrial health in osteoarthritis models. Areas such as skin, gut, brain, and heart remain firmly at the early, preclinical stage — interesting directions that laboratory and animal work is exploring, not benefits demonstrated in people. It is worth being precise here: a rodent result is a reason to run a human trial, not a substitute for one.

How to compare SOMA HEALTH and Neurogan fairly

Dose

Human trials have used a range of roughly 500 to 1,000 mg per day, with 1,000 mg representing the top of the studied range. SOMA HEALTH sits at that 1,000 mg ceiling per daily serving. When you evaluate any Neurogan option, the first question is how many capsules you need to reach a dose that matches what the studies actually used — a lower per-serving amount is not wrong, but it changes how the product maps onto the evidence. Our dosage guide breaks down how the studied amounts translate to daily servings.

Format and adherence

The best dose is the one you actually take consistently. Capsules are compact and familiar; some people prefer them and can swallow several at once without issue. A gummy removes the pill-swallowing barrier and, for many people, is simply more pleasant, which supports the daily consistency these longer trials required. Neither format changes the underlying molecule. If capsules are a chore for you, a gummy may quietly improve adherence; if you dislike sweet textures, a capsule may suit you better.

Testing and transparency

Because urolithin A is a manufactured ingredient, third-party testing matters for confirming identity and purity. SOMA HEALTH is third-party tested. When comparing any brand, look for published or available certificates of analysis and clear per-serving labeling rather than only a large 'total milligrams in the bottle' figure, which can make a product look stronger than its per-serving dose really is.

Value

Judge cost by price per gram of urolithin A per day, not sticker price. SOMA HEALTH is $79 for a 30-day supply at 1,000 mg per day (120 gummies). To compare Neurogan honestly, work out how many capsules deliver an equivalent daily dose and divide accordingly, using their current label. This apples-to-apples math often matters more than any headline number. For a broader field, see our roundup of the best urolithin A gummies.

A note on health conditions

Urolithin A is studied as a structure/function ingredient that supports mitochondrial and muscle health. It is not a treatment for any disease, and this comparison is not medical advice. If you are managing a specific condition, are pregnant or nursing, or take medication, urolithin A is not a treatment — talk with your doctor before starting any supplement. For more on tolerability, see urolithin A side effects.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.